Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO]
Clinical trial NCT03555422 · COMPLETED
Trial details
- NCT number
- NCT03555422
- Sponsor
- Karyopharm Therapeutics Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-05
- Primary completion
- 2022-01-22
- Enrollment
- 263
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.